T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTXS
951
DELISTED
Citrix Systems Inc
CTXS
| $16.9M | ﹤0.01% |
162,188
-3,455,084
| -96% | -$354M |
|
952
Allegion
ALLE
$14.2B
| $16.8M | ﹤0.01% |
186,928
-1,971
| -1% | -$195K |
|
953
Asbury Automotive
ABG
$3.78B
| $16.7M | ﹤0.01% |
110,675
-14,666
| -12% | -$2.5M |
|
954
Akamai
AKAM
$18B
| $16.7M | ﹤0.01% |
207,984
-1,135,547
| -85% | -$103M |
|
955
NCR Voyix
VYX
$1.17B
| $16.7M | ﹤0.01% |
1,429,446
-517,001
| -27% | -$9.49M |
|
956
Hormel Foods
HRL
$13.4B
| $16.7M | ﹤0.01% |
366,758
-2,296
| -0.6% | -$111K |
|
957
Home BancShares
HOMB
$6.27B
| $16.6M | ﹤0.01% |
738,494
-9,941,200
| -93% | -$231M |
|
|
MODV
958
DELISTED
ModivCare
MODV
| $16.6M | ﹤0.01% |
166,770
-641,271
| -79% | -$66.4M |
|
|
CCXI
959
DELISTED
ChemoCentryx, Inc.
CCXI
| $16.6M | ﹤0.01% |
320,461
+10,332
| +3% | +$427K |
|
960
Nordson
NDSN
$17.3B
| $16.5M | ﹤0.01% |
77,942
+5,980
| +8% | +$1.34M |
|
961
Alector
ALEC
$228M
| $16.5M | ﹤0.01% |
1,743,391
-104,734
| -6% | -$1.13M |
|
962
Federal Signal
FSS
$7.51B
| $16.4M | ﹤0.01% |
439,742
-2,359,655
| -84% | -$92.7M |
|
963
Constellium
CSTM
$3.95B
| $16.4M | ﹤0.01% |
1,614,729
-14,317,895
| -90% | -$190M |
|
|
ITCI
964
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $16.3M | ﹤0.01% |
350,956
+310,214
| +761% | +$16.2M |
|
965
Duolingo
DUOL
$6.74B
| $16.3M | ﹤0.01% |
170,788
-955,377
| -85% | -$93M |
|
966
Ambev
ABEV
$43.8B
| $16.2M | ﹤0.01% |
5,728,800
+66,600
| +1% | +$189K |
|
967
Mercury Systems
MRCY
$6.59B
| $16.2M | ﹤0.01% |
398,954
+19,820
| +5% | +$1.04M |
|
|
VSXY
968
Victoria's Secret
VSXY
$7.24B
| $16.2M | ﹤0.01% |
554,855
+1,013
| +0.2% | +$34.1K |
|
969
Evertec
EVTC
$1.91B
| $16.1M | ﹤0.01% |
512,254
+4,441
| +0.9% | +$156K |
|
970
UDR
UDR
$12.2B
| $16M | ﹤0.01% |
382,800
-2,271
| -0.6% | -$104K |
|
|
GRMN
971
Garmin
GRMN
$60.2B
| $15.9M | ﹤0.01% |
198,108
+1,119
| +0.6% | +$106K |
|
972
Teradata
TDC
$2.57B
| $15.8M | ﹤0.01% |
508,800
-361,094
| -42% | -$12.6M |
|
973
Healthpeak Properties
DOC
$14.3B
| $15.8M | ﹤0.01% |
689,228
-6,554
| -0.9% | -$173K |
|
974
Service Corp International
SCI
$11.3B
| $15.7M | ﹤0.01% |
272,732
-23,488
| -8% | -$1.55M |
|
975
LCI Industries
LCII
$2.6B
| $15.7M | ﹤0.01% |
154,587
-521,105
| -77% | -$63.3M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.